Video

 

TR10: Dual-Action Antibodies

03:16

At Genentech, one of this year?s TR10 innovators, Germaine Fuh is developing a new variety of drug that can target more than one type of molecule, potentially reducing costs and simplifying treatment. We asked Fuh how it worked and what it might…

This video appeared in the story

May 8, 2017

Latest videos

Intelligent Machines

AI's Economic Impact   35:20

Partner content

{! video.topicName !}


{! video.duration !}

Loading…